Vanguard Group Inc Moderna, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 39,036,872 shares of MRNA stock, worth $4.64 Billion. This represents 0.08% of its overall portfolio holdings.
Number of Shares
39,036,872
Previous 33,907,072
15.13%
Holding current value
$4.64 Billion
Previous $3.37 Billion
23.36%
% of portfolio
0.08%
Previous 0.07%
Shares
13 transactions
Others Institutions Holding MRNA
# of Institutions
1,036Shares Held
245MCall Options Held
12.1MPut Options Held
9.36M-
Baillie Gifford & CO44.7MShares$5.3 Billion3.77% of portfolio
-
Black Rock Inc. New York, NY25.4MShares$3.02 Billion0.06% of portfolio
-
State Street Corp Boston, MA14.5MShares$1.72 Billion0.07% of portfolio
-
Flagship Pioneering Inc. Cambridge, MA9.67MShares$1.15 Billion67.87% of portfolio
-
Theleme Partners LLP London, X07.32MShares$869 Million39.54% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $46.5B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...